OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI agent that can act

Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year.

OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance, and event planning.

Musk has raised questions on project Stargate, the $500bn AI project. This lead to a verbal spat between him and Sam Altman.

Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources as saying that Sam Altman is participating in the investment. He previously provided the initial $180 million funding round that helped launch Retro.

President Donald Trump spoke with OpenAI CEO Sam Altman by phone Friday, ahead of the AI infrastructure announcement, CNBC has learned.

OpenAI CEO Sam Altman suggested Elon Musk cares more about his businesses than he does the country, shortly after he referred to Musk as "the most inspiring entrepreneur of our time."

"And of course it's smarter than us. Of course, it can do things we can't, but also who really cares? I think it's only weird for us in this one transition time."

WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break up OpenAI and Microsoft.

Karoline Leavitt, Donald Trump 's White House Press Secretary, spoke about Elon Musk for the first time since the Trump ally's criticism of Stargate, a new entity that plans to invest $500 billion in U.S. artificial intelligence (AI) infrastructure.

Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam Altman.